Opinion statement
Management of atrial fibrillation, premature ventricular contractions, and ventricular tachycardia without underlying cardiac disease or arrhythmogenic conditions differs in athletes from the general population. Athletes tend to be younger, healthier individuals with few comorbidities. Therapies that work well in the general population may not be appropriate or preferable for athletes. Management strategies include deconditioning, pharmacologic therapy, such as rate control with β-blockers or non-dihydropyridine calcium channel blockers and rhythm control with class I or class III antiarrhythmic drugs, and catheter ablation. Deconditioning is not preferred by athletes because of lost playing time. Pharmacologic therapy is well tolerated among most individuals, but is not as favorable in athletes. Rate control medications can reduce performance and β-blockers, in particular, are prohibited in many sports. Antiarrhythmic drugs are preferred over rate control with athletes, but many, especially younger athletes, may not like the idea of long-term medical therapy. Catheter ablation has been proven to be safe and efficacious, may eliminate the need for long-term medical therapy, and is supported by the major societies (AHA, ACC, ESC).
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Guasch E, Mont L. Diagnosis, pathophysiology, and management of exercise-induced arrhythmias. Nat Rev Cardiol [Internet] Nature Publishing Group. 2016;14:88–101. Available from: http://www.nature.com/doifinder/10.1038/nrcardio.2016.173. Excellent review of pathophysiology, evaluation, and management of exercise-induced arrhythmias.
Walker J, Calkins H, Nazarian S. Evaluation of cardiac arrhythmia among athletes. Am J Med [Internet]. 2010;123:1075–81. Available from: http://www.sciencedirect.com/science/article/pii/S0002934310004559
•• Sharma S, Merghani A, Mont L. Exercise and the heart: the good, the bad, and the ugly. Eur Heart J. 2015;36:1445–53. Excellent review of the effects of exercise on the heart.
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071–104.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.
Zimetbaum P. Atrial fibrillation. Ann Intern Med [Internet]. 2017;166:ITC33. Available from: http://annals.org/article.aspx?doi=10.7326/AITC201703070
Baldesberger S, Bauersfeld U, Candinas R, Seifert B, Zuber M, Ritter M, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29:71–8.
Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaëlsson K, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013;34:3624–31.
Turagam MK, Flaker GC, Velagapudi P, Vadali S, Alpert MA. Atrial fibrillation in athletes: pathophysiology, clinical presentation, evaluation and management. J Atr Fibrillation [Internet]. 2016;8:66–72. Available from: http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=112930379&site=ehost-live
Elliott AD, Mahajan R, Lau DH, Sanders P. Atrial fibrillation in endurance athletes: from mechanism to management. Cardiol Clin [Internet]. Elsevier Inc. 2016;34:567–78. https://doi.org/10.1016/j.ccl.2016.06.006.
Walters TE, Lee G, Spence S, Larobina M, Atkinson V, Antippa P, et al. Acute atrial stretch results in conduction slowing and complex signals at the pulmonary vein to left atrial junction: insights into the mechanism of pulmonary vein arrhythmogenesis. Circ Arrhythmia Electrophysiol. 2014;7:1189–97.
Ueda N, Yamamoto M, Honjo H, Kodama I, Kamiya K. The role of gap junctions in stretch-induced atrial fibrillation. Cardiovasc Res. 2014;104:364–70.
•• Zipes DP, Link MS, Ackerman MJ, Kovacs RJ, Myerburg RJ, Estes NAM. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66:2412–23. Most recent consensus statement on the evaluation and management of arrhythmias in athletes.
Biffi A, Pelliccia A, Verdile L, Fernando F, Spataro A, Caselli S, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol [Internet] Elsevier Masson SAS. 2002;40:446–52. https://doi.org/10.1016/S0735-1097(02)01977-0.
Delise P, Sitta N, Lanari E, Berton G, Centa M, Allocca G, et al. Long-term effect of continuing sports activity in competitive athletes with frequent ventricular premature complexes and apparently normal heart. Am J Cardiol. 2013;112:1396–402.
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol [Internet]. 2006;48:e247–346. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0735109706018171
Biffi A. Idiopathic ventricular arrhythmias in athletes: their causes and when to grant sports eligibility. J Cardiovasc Med (Hagerstown) [Internet]. 2006;7:279–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16645402
Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J [Internet]. 2015;36:2793–867. Available from: https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehv316
Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Europace. 2009;11:771–817.
Michowitz Y, Viskin S, Rosso R. Exercise-induced ventricular tachycardia/ventricular fibrillation in the normal heart: risk stratification and management. Card Electrophysiol Clin [Internet] Elsevier Inc. 2016;8:593–600. https://doi.org/10.1016/j.ccep.2016.04.008.
Biffi A. How to manage athletes with ventricular arrhythmias. Cardiol Clin. 2007;25:449–55.
Link MS, Mark Estes NA. Athletes and arrhythmias. J Cardiovasc Electrophysiol. 2010;21:1184–9.
Katritsis DG, Zareba W, Camm AJ. Nonsustained ventricular tachycardia. J Am Coll Cardiol [Internet] Elsevier Inc. 2012;60:1993–2004. https://doi.org/10.1016/j.jacc.2011.12.063.
Heidbuchel H, Prior DL, La Gerche A. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? Br J Sports Med [Internet]. 2012;46:i44–50. Available from: http://bjsm.bmj.com/lookup/doi/10.1136/bjsports-2012-091162
James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62:1290–7.
Pitzalis MV, Mastropasqua F, Massari F, Passantino A, Forleo C, Luzzi G, et al. Dependency of premature ventricular contractions on heart rate. Am Heart J. 1997;133:153–61.
Biffi A, Maron BJ, Culasso F, Verdile L, Fernando F, Di Giacinto B, et al. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol [Internet] Elsevier Inc. 2011;107:697–703. https://doi.org/10.1016/j.amjcard.2010.10.049.
Latchamsetty R, Bogun F. Premature ventricular complex-induced cardiomyopathy. Rev Española Cardiol. 2016;69:365–9.
Aizer A, Gaziano JM, Cook NR, Manson JE, Buring JE, Albert CM. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol [Internet]. Elsevier Inc. 2009;103:1572–7. https://doi.org/10.1016/j.amjcard.2009.01.374.
Drca N, Wolk A, Jensen-Urstad M, Larsson SC. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart [Internet]. 2014;100:1037–42. Available from: http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2013-305304
Thelle DS, Selmer R, Gjesdal K, Sakshaug S, Jugessur A, Graff-Iversen S, et al. Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309 540 men and women. Heart [Internet]. 2013;99:1755–60. Available from: http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2013-303825
Bapat A, Zhang Y, Post WS, Guallar E, Soliman EZ, Heckbert SR, et al. Relation of physical activity and incident atrial fibrillation (from the multi-ethnic study of atherosclerosis). Am J Cardiol [Internet]. Elsevier Inc. 2015;116:883–8. https://doi.org/10.1016/j.amjcard.2015.06.013.
Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Med dello Sport. 2005;58:157–91.
Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med [Internet]. 2006;354:934–41. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa050955
Latchamsetty R, Morady F. Catheter ablation of atrial fibrillation. Heart fail Clin [Internet]. Elsevier Inc. 2016;12:223–33. https://doi.org/10.1016/j.hfc.2015.08.018.
Sorgente A, Chierchia GB, De Asmundis C, Sarkozy A, Capulzini L, Brugada P. Complications of atrial fibrillation ablation: when prevention is better than cure. Europace. 2011;13:1526–32.
Calvo N, Mont L, Tamborero D, Berruezo A, Viola G, Guasch E, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010;12:30–6.
Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13:1386–93.
Furlanello F, Lupo P, Pittalis M, Foresti S, Vitali-Serdoz L, Francia P, et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol. 2008;19:457–62.
Gallagher C, Hendriks JML, Mahajan R, Middeldorp ME, Elliott AD, Pathak RK, et al. Lifestyle management to prevent and treat atrial fibrillation. Expert Rev Cardiovasc Ther [Internet] Taylor & Francis. 2016;14:799–809. Available from: http://www.tandfonline.com/doi/full/10.1080/14779072.2016.1179581
Biffi A, Maron BJ, Verdile L, Fernando F, Spataro A, Marcello G, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol [Internet]. Elsevier Masson SAS. 2004;44:1053–8. https://doi.org/10.1016/j.jacc.2004.05.065.
Delise P, Lanari E, Sitta N, Centa M, Allocca G, Biffi A. Influence of training on the number and complexity of frequent VPBs in healthy athletes. J Cardiovasc Med (Hagerstown). 2011;12:157–61.
John RM, Stevenson WG. Outflow tract premature ventricular contractions and ventricular tachycardia: the typical and the challenging. Card Electrophysiol Clin [Internet]. Elsevier Inc. 2016;8:545–54. https://doi.org/10.1016/j.ccep.2016.04.004.
Saeid AK, Klein GJ, Leong-Sit P. Sustained ventricular tachycardia in apparently normal hearts. Card Electrophysiol Clin [Internet]. Elsevier Inc. 2016;8:631–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1877918216300685
Ling Z, Liu Z, Su L, Zipunnikov V, Wu J, Du H, et al. Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract prospective randomized study. Circ Arrhythmia Electrophysiol. 2014;7:237–43.
Rorvik SD, Chen J, Hoff PI, Solheim E, Schuster P. 10-year follow-up after radiofrequency ablation of idiopathic ventricular arrhythmias from right ventricular outflow tract. Indian Pacing Electrophysiol J [Internet] Elsevier Ltd. 2016;16:88–91. https://doi.org/10.1016/j.ipej.2016.08.005.
Latchamsetty R, Yokokawa M, Morady F, Kim HM, Mathew S, Tilz R, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC Clin Electrophysiol. 2015;1:116–23.
Fichtner S, Senges J, Hochadel M, Tilz R, Willems S, Eckardt L, et al. Safety and efficacy in ablation of premature ventricular contraction: data from the German ablation registry. Clin Res Cardiol. 2017;106:49–57.
Katz DF, Turakhia MP, Sauer WH, Tzou WS, Heath RR, Zipse MM, et al. Safety of ventricular tachycardia ablation in clinical practice. Circ Arrhythmia Electrophysiol. 2015;8:362–70.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Sports Cardiology
Rights and permissions
About this article
Cite this article
Lai, E., Chung, E.H. Management of Arrhythmias in Athletes: Atrial Fibrillation, Premature Ventricular Contractions, and Ventricular Tachycardia. Curr Treat Options Cardio Med 19, 86 (2017). https://doi.org/10.1007/s11936-017-0583-x
Published:
DOI: https://doi.org/10.1007/s11936-017-0583-x